<SEC-DOCUMENT>0001047469-19-003649-index.html : 20190614
<SEC-HEADER>0001047469-19-003649.hdr.sgml : 20190614
<ACCEPTANCE-DATETIME>20190614162342
ACCESSION NUMBER:		0001047469-19-003649
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20190731
FILED AS OF DATE:		20190614
DATE AS OF CHANGE:		20190614
EFFECTIVENESS DATE:		20190614

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nabriva Therapeutics plc
		CENTRAL INDEX KEY:			0001641640
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L2
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37558
		FILM NUMBER:		19899216

	BUSINESS ADDRESS:	
		STREET 1:		56 FITZWILLIAM SQUARE
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			2
		BUSINESS PHONE:		(610) 816-6640

	MAIL ADDRESS:	
		STREET 1:		1000 CONTINENTAL DRIVE
		STREET 2:		SUITE 600
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Nabriva Therapeutics AG
		DATE OF NAME CHANGE:	20150507
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>a2239045zdef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
Document 1 - file: a2239045zdef14a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g50439.jpg
<DESCRIPTION>G50439.JPG
<TEXT>
Document 2 - file: g50439.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g761950.jpg
<DESCRIPTION>G761950.JPG
<TEXT>
Document 3 - file: g761950.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g114982bci001.gif
<DESCRIPTION>G114982BCI001.GIF
<TEXT>
Document 4 - file: g114982bci001.gif

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g114982bci002.gif
<DESCRIPTION>G114982BCI002.GIF
<TEXT>
Document 5 - file: g114982bci002.gif

</DOCUMENT>
</SEC-DOCUMENT>